Noradrenaline-selective versus serotonin-selective antidepressant therapy: Differential effects on social functioning

Journal of Psychopharmacology

Volumn 11, Issue 4 SUPPL., 1997, Pages

  Dubini, Adriana ^a   Bosc, Marc ^b   Polin, Valerie ^b  

^a Clinical Development Consultant   (Italy)

^b Pharmacia and Upjohn   (France)

Author keywords

Depression; Fluoxetine; Reboxetine; Remission; Social functioning

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; NORADRENALIN UPTAKE INHIBITOR; REBOXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REMISSION; SELF CONCEPT; SELF EVALUATION; SOCIAL BEHAVIOR; SOCIAL INTERACTION;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; MALE; MIDDLE AGED; MORPHOLINES; NOREPINEPHRINE; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SOCIAL BEHAVIOR;

EID: 0030735990     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Agosti V, Steward J W, Quitkin F M (1991) Life satisfaction and psychosocial functioning in chronic depression: effect of acute treatment with antidepressants. J Affect Disord 23: 35-41
2. American Psychiatric Association (1987) Diagnostic and statistical manual for mental disorders, 3rd rev edn. American Psychiatric Association, Washington DC
3. Bosc M, Dubini A, Polin V (1997) Development and validation of a social functioning scale, the Social Adaptation Self-evaluation Scale. Eur Neuropsychopharmacol 7 (Suppl. 1): S57-S70
4. Carlsson A, Corrodi H, Fuxe K et al. (1969) Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-ethyl-metathyramine. Eur J Clin Pharmacol 5: 357-366
5. Dubini A, Bosc M, Polin V (1997) Do noradrenaline and serotonin differentially affect social motivation and behaviour? Eur Neuropsychopharmacol 7 (Suppl. 1): S49-S55
6. Duncan D B (1955) Multiple range and multiple F tests. Biometrics 11: 1-42
7. Guilford J P, Fruchter B (1981) Fundamental statistics in psychology and education. McGraw-Hill, Singapore, pp. 308-311
8. Guy W (1976) Clinical global impressions. In ECDEU assessment manual for psychopharmacology, rev edn. pp. 217-222
9. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62
10. Hays R D, Wells K B, Sherbourne C D, Rogers W, Spriber K (1995) Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch Gen Psychiatry 52: 11-19
11. Kocsis J H, Frances A J, Voss C, Mason B J, Mann J J, Sweeney J (1988) Imipramine and social-vocational adjustment in chronic depression. Am J Psychiatry 145(8): 997-999
12. Laeder J B, Klein D N (1996) Social adjustment in dysthymia, double depression and episodic major depression. J Affect Disord 37: 91-101
13. Maas J W (1975) Biogenic amines and depression. Arch Gen Psychiatry 32: 1357-1361
14. Montgomery S A (1997) Reboxetine: additional benefits to the depressed patient. J Psychopharmacol 11(Suppl.): S9-S15
15. Montgomery S A, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382-389
16. Snedecor G W (1946) Statistical methods, 4th edn. Iowa State College Press, Ames, IA
17. Weissman M M, Klerman G L, Paykel E S (1974) Treatment effects on the social adjustment of depressed patients. Arch Gen Psychiatry 30: 771-778
18. Weissmann M M, Bothwell S (1976) Assessment of social adjustment by patient self report. Arch Gen Psychiatry 33: 1111-1115